Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.36 USD
Change Today +0.08 / 1.27%
Volume 296.9K
ECYT On Other Exchanges
As of 4:30 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Binh Nguyen M.D., Ph.D.

Vice President of Medical Affairs, Endocyte, Inc.
AgeTotal Calculated CompensationThis person is connected to 16 board members in 1 different organizations across 3 different industries.

See Board Relationships
As of Fiscal Year 2013


Mr. Binh Nguyen, M.D., Ph.D has been Vice President of Medical Affairs of Endocyte, Inc. since June 15, 2011. Dr. Nguyen has more than 20 years of experience in clinical drug development. He served as Chief Medical Officer and Vice President of Clinical Development at Tigris Pharmaceuticals, Inc. He served as Vice President of Clinical Development and Regulatory Affairs at Tigris Pharmaceuticals since September 2005. He worked at Eli Lilly for 10 years. He served as ...

Read Full Background

Corporate Headquarters*

3000 Kent Avenue
West Lafayette, Indiana 47906

United States

Phone: 765-463-7175
Fax: 765-463-9271

Board Members Memberships*

There is no Board Members Memberships data available.


Georgetown University
Georgetown University
University of Maryland

Other Affiliations*

Annual Compensation*

Total Annual Compensation$435,580

Stock Options*

All Other Compensation$840
Exercised Options20,000
Exercised Options Value$215,649
Exercisable Options44,000
Unexercisable Options174,000
Unexercisable Options Value$485,200
Total Value of Options$700,849
Total Number of Options238,000

Total Compensation*

Total Annual Cash Compensation$436,420
Total Short Term Compensation$435,580
Other Long Term Compensation$840
Total Calculated Compensation$988,545
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECYT:US $6.36 USD +0.08


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENDOCYTE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at